�A fast, flexible, and reliable isolation of pure nucleic acids from diverse sample materials is important for sensible molecular analytic thinking by PCR, RT-PCR, sequencing, arrays etc. In addition, automation of nucleic acid isolation is becoming increasingly important for reproducibility and to reduce experimental error. During the last long time, demands regarding hardware innovation, software, and operating system have been increasing. The new MagNA Pure LC 2.0 System from Roche Applied Science nowadays meets all requirements for a modern nucleic acid purification system. It shows all features and the performance of the first base generation pawn and comprises in addition a roll up of improvements including a complete redesign of the housing, optimized handling, an integrated calculator and LCD monitor with touch screen, new software package, and LIMS/network compatibility.
The new front door of the MagNA Pure LC 2.0 System requires less space above the instrument; the new surface materials of the stage proved to be resistive to all tested cleanup agents. The new GUI together with the touch screen allows efficient programming and data processing, and the real time PCR work flow with the Light Cycler� 480 System is improved. The scheduling of pipetting schemes for various PCR set-ups bathroom easily be done by a divide post-elution package. The mistake handling of the organisation has been significantly improved.
The MagNA Pure LC System from Roche Applied Science has been on the market since 1999. This fully automated ("walkaway") system is based on the well-established magnetic bead technology and offers a great variety show of applications. The organization is designed to automatize nucleic acidic purification and PCR setup in the medium to high throughput range, flexibly processing 1-32 samples at a clip. The duration to purify a full batch of 32 samples is 52-180 minutes, depending on the application. Smaller batches require even shorter run duration. As shown in many publications, the MagNA Pure LC System has proven to be a versatile and dependable tool for isolation of very pure nucleic acids of high integrity (for details on references inspect our MagNA Pure Special Interest Site at hTTP://www.magnapure.com).
About Roche
Headquartered in Basel, Switzerland, Roche is unitary of the world's leading research-focused health care groups in the w. C. Fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and timber of life. Roche is the world leader in in-vitro diagnostics and drugs for crab and transplant, and is a market leader in virology. It is besides active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central spooky system. In 2007 sales by the Pharmaceuticals Division totalled 36.8 one thousand million Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 one thousand million Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is uncommitted on the Internet at http://www.roche.com.
All other brands and product name calling are trademarks of their respective holders.
Roche
More info
